A detailed history of Ameritas Advisory Services, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 25 shares of BIO stock, worth $7,828. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 32 21.88%
Holding current value
$7,828
Previous $7,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$241.95 - $303.82 $1,693 - $2,126
-7 Reduced 21.88%
25 $7,000
Q2 2025

Jul 21, 2025

BUY
$216.56 - $256.68 $6,929 - $8,213
32 New
32 $7,000
Q1 2023

Apr 28, 2023

BUY
$418.69 - $503.0 $837 - $1,006
2 New
2 $0

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.71B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.